DiA Imaging Analysis is a leading global provider of FDA-cleared and CE-marked ultrasound AI software that automates how clinicians use and analyze ultrasound images. The company's LVivo product line for cardiac and abdominal automated analysis allows clinicians with varying levels of ultrasound experience to automatically analyze ultrasound images increasing speed, efficiency, and accuracy. Our AI-based cardiac ultrasound analysis software LVivo Seamless™ runs behind-the-scenes, automatically selecting and analyzing the optimal apical views, then generating reproducible and accurate key measurements including Strain, EF and RV size and function on every echo exam. Today, DiA serves thousands of end-users worldwide. DiA was recognized as one of Fast Company's 2022 World Changing Ideas in the Health Category and was recently named as one of CB Insights' most innovative digital health startups. 

Israel Innovation Authority

Mindset Ventures

AltaIR Capital

ShengJing360

iVentures Asia Ltd

Connecticut Innovations

CE Ventures (CEIIF)

DEFTA Partners

Philips Venture Capital Fund

XTX Ventures

Alchimia Investments

ICON Community Fund

Downing Ventures

Shmuel Cabilly

DiA Imaging Analysis

DiA Imaging Analysis leverages AI to provide AI-powered ultrasound analysis software that makes the use and analysis of ultrasound images smarter, more accessible, and vendor-neutral. Their solutions aim to support clinicians with various analysis experience levels and improve the accuracy and efficiency of ultrasound image analysis.

COM:DIA-ANALYSIS

DiA Imaging Analysis

Filings Not Available